UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038229
Receipt number R000043551
Scientific Title Evaluation of genetic counseling for disclosure of research-identified genetic mutations in breast cancer patients: a multicenter prospective observational cohort study
Date of disclosure of the study information 2019/10/08
Last modified on 2023/10/03 12:59:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of genetic counseling for disclosure of research-identified genetic mutations in breast cancer patients: a multicenter prospective observational cohort study

Acronym

Evaluation of genetic counseling for disclosure of research-identified genetic mutations

Scientific Title

Evaluation of genetic counseling for disclosure of research-identified genetic mutations in breast cancer patients: a multicenter prospective observational cohort study

Scientific Title:Acronym

Evaluation of genetic counseling for disclosure of research-identified genetic mutations

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

identify their requirements based on assessment of genetic counseling for disclosure of research-identified genetic mutations through an established questionnaire completed by the clients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The change in GCOS-24 score between before and after genetic counseling (GCOS-24:The Genetic Counseling Outcome Scale)

Key secondary outcomes

Associations between the changes in GCOS-24 scores and patient factors


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following
1. Diagnosis as a carrier of a clinically actionable germline pathogenic/likely pathogenic genetic mutation (BRCA1, BRCA2, ATM, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11, TP53, BRIP1, MSH2, MLH1, MSH6, PMS2, EPCAM, RAD51C, RAD51D, RYR2, RB1)in the previous study(Kyoto University Ethical Committe G424)
2. Regular follow-up in the participating hospitals
3. Consent to disclosure of the research results, genetic counseling and this study

Key exclusion criteria

Patients who meet one of the following
1. Lost to follow-up
2. Declining disclosure of the research results, genetic counseling, or participation in this study
3. Previous genetic counseling and diagnosis as a carrier on clinical genetic testing

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Nobuko
Middle name
Last name Kawaguchi-Sakita

Organization

Kyoto University Hospital

Division name

Clinical Oncology

Zip code

606-8507

Address

54 Shogoin Kawara-cho Sakyo-ku, Kyoto

TEL

075-751-3660

Email

nobuko75@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Nobuko
Middle name
Last name Kawaguchi-Sakita

Organization

Kyoto University Hospital

Division name

Clinical Oncology

Zip code

606-8507

Address

54 Shogoin Kawara-cho Sakyo-ku, Kyoto

TEL

075-751-3660

Homepage URL


Email

nobuko75@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto university Graduate School and Faculty of Medicine, Kyoto University Hospital Ethics Committe

Address

Yoshidakonoe-cho Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

122

Org. issuing International ID_1

Japan Breast Cancer Society

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公益財団法人 田附興風会 医学研究所 北野病院(大阪府)
日本赤十字社 大阪赤十字病院(大阪府)
今井会足立病院 京都ブレストセンター 沢井記念乳腺クリニック(京都府)
地域医療機能推進機構 大和郡山病院(奈良県)
国家公務員共済組合連合会 枚方公済病院(大阪府)
医療法人神鋼会 神鋼病院(兵庫県)
京都市立病院(京都府)
地方独立行政法人 神戸市民病院機構 神戸市立医療センター中央市民病院(兵庫県)
大和高田市立病院(奈良県)
日本赤十字社和歌山医療センター(和歌山県)
滋賀県立総合病院(滋賀県)
兵庫県立尼崎総合医療センター(兵庫県)
菅典道クリニック(京都府)
大津市民病院(滋賀県)
洛和会音羽病院(京都府)


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 11 Month 30 Day

Date of IRB

2017 Year 11 Month 30 Day

Anticipated trial start date

2017 Year 12 Month 20 Day

Last follow-up date

2022 Year 07 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Based on assessment of genetic counseling for disclosure of research-identified genetic mutations through an established questionnaire completed by the clients,their requirements will be identified.


Management information

Registered date

2019 Year 10 Month 07 Day

Last modified on

2023 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043551